Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities

Fig. 1

Rapidly induced cell autonomous bypass signaling. a Using EGFR mutated lung tumors as an example, oncogenic EGFR signals through the MEK/ERK pathway to drive growth and survival, but also suppresses FGFR2, FGFR3 and TGFβ2 expression. b Upon treatment with EGFR-specific TKIs, MEK/ERK activity is inhibited to reduce growth and survival signaling, but also de-represses alternative bypass growth and survival pathways including FGFR2, FGFR3, TGFβ2 and IL6. EGFR TKIs increase NFκB pathway activity which may drive expression of IL6 [36]. These transcriptional changes result in establishment of emergent autocrine loops to ensure the continued growth and survival of the tumor in the presence of an EGFR inhibitor

Back to article page

Molecular Cancer

ISSN: 1476-4598